Vanderbilt-Ingram Cancer Center

Colorectal cancer is the second leading cancer killer of men and women over 50. Since colorectal cancer doesn’t always cause symptoms, you can look healthy and feel fine and not know there may be a problem. The only way to know is by getting screened. Screening can find precancerous polyps, so they can be removed [...]

by Dagny Stuart Vanderbilt-Ingram Cancer Center’s Mace Rothenberg, M.D., has been named one of the nation’s top cancer caregivers by the American Cancer Society. He is one of eight care providers from a variety of backgrounds and regions chosen to receive the 2008 American Cancer Society Lane W. Adams Quality of Life Award, a national [...]

A technique that specifically “tags” tumors responding to chemotherapy may offer a new strategy for determining a cancer treatment’s effectiveness within days of starting treatment, according to a new study by Vanderbilt-Ingram Cancer Center investigators. Appearing online ahead of print in Nature Medicine, the researchers report the identification of a small protein that specifically recognizes [...]

When it comes to the genders, cancer is an equal opportunity disease. While slightly more men develop and die of cancer than do women, cancer still will be diagnosed in 1 of every 3 women during her lifetime. Knowing about cancer, you can prevent various types or detect them early. To help you, we have [...]

by Dagny Stuart Scott Hiebert, Ph.D., has been named associate director for Basic Science Programs at Vanderbilt-Ingram Cancer Center. Hiebert, professor of Biochemistry and Leader of the Signal Transduction and Cellular Proliferation Program, succeeds Jennifer Pietenpol, Ph.D., who was recently named director of the Cancer Center. “Vanderbilt-Ingram Cancer Center is winning international recognition for the [...]

Silence is often the first barrier to progress against cancer, Tennessean columnist Dwight Lewis writes. This column highlights the Witness Project as one of the promising steps being taken to address the gaps in cancer incidence and deaths between black and white members of our community. The Witness Project, supported by Susan G. Komen for [...]

by Melissa Marino Transforming growth factor-beta (TGF-beta) is a fickle protein. While it suppresses cell division and inhibits tumor growth in the early stages of cancer, it can also promote tumor cell growth and metastasis in later stages. However, the reasons behind this switch in function are not clear. A team of Vanderbilt-Ingram Cancer Center [...]

Thanks to a three-year grant from the American Cancer Society, Sheila Ridner, Ph.D., R.N., assistant professor of Nursing at the Vanderbilt University School of Nursing, and Ingrid Mayer, M.D., assistant Professor of Medicine at the Vanderbilt-Ingram Cancer Center, are testing expressive writing as a way to help alleviate some physical and psychological consequences of stage 2 lymphedema in breast cancer survivors.

by Jessica Ennis The Monroe Carell Jr. Children’s Hospital at Vanderbilt will host several regional and international thinkers in the realm of pediatric cancer treatment and research at two separate meetings taking place Feb. 1-5. The inaugural Acute Lymphoblastic Leukemia (ALL) New Agents Conference will be held Feb. 1-2, bringing together eight groups with an [...]